Lataa...

Design innovations and baseline findings in a long-term Parkinson’s trial: NET-PD LS-1

BACKGROUND: Based on the pre-clinical and the results of a phase 2 futility study, creatine was selected for an efficacy trial in Parkinson’s disease (PD). We present the design rationale and a description of the study cohort at baseline. METHODS: A randomized, multicenter, double-blind, parallel gr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3481179/
https://ncbi.nlm.nih.gov/pubmed/23079770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25175
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!